Description: Deva Holding A.S. manufactures and sells pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, and sensory organs. In addition, the company offers cephalosporins, penicillin, inhalation products, solid and liquid oncology, animal health products, active pharmaceutical ingredients, ampoules, liquid and lyophilized vials, eye drops, medical ampoules for sterile injectable products, and cologne. It also exports its products to approximately 60 countries. The company was incorporated in 1958 and is based in Istanbul, Turkey. Deva Holding A.S. is a subsidiary of Eastpharma S.à R.L.
Home Page: www.deva.com.tr
Halkali Merkez Mah.
Istanbul,
34303
Turkey
Phone:
90 212 692 92 92
Officers
| Name | Title |
|---|---|
| Mr. Philipp Anthony Haas | Chairman & CEO |
| Mr. Mesut Çetin | Deputy Chairman & CFO |
| Riza Yildiz | Financial Reporting & Accounting Director |
| Tijen Kavlak | Marketing & Communication Director |
| Gülseren Mahmutoglu | Deputy Mang. of Treasury & Shareholder Relations |
| Dogan Varinlioglu | Deputy Gen. Mang. of Turkey & International Markets |
| Hartwig Andreas Steckel | R&D Director |
Exchange: IS
Country: TR
Currency: Turkish lira (₺)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 7.1616 |
| Price-to-Book MRQ: | 3.3742 |
| Price-to-Sales TTM: | 3.1829 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2820 |